Concepedia

Publication | Closed Access

Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study

654

Citations

31

References

2012

Year

References

YearCitations

Page 1